Photo of a scientist

01

Who We Are

Deeply integrated,

deeply invested

Relay Therapeutics® is a clinical-stage precision medicine company transforming the drug discovery process.

Relay Therapeutics' Approach

Relay Therapeutics was built upon unparalleled insights into protein motion and how this dynamic behavior relates to protein function. These insights are driven by our Dynamo platform, which integrates an array of leading-edge experimental and computational approaches and enables us to effectively drug protein targets that have previously been intractable or inadequately addressed.

Three important forces led to the

founding of Relay Therapeutics:

Genomic Data

Computational

Experimental

Genomic Data

The genomic revolution has enabled a better understanding of the targets that drive disease, and which patients may benefit from new targeted therapies.

1999

2003

2009

2012

2016

Late 1990s

2007

2012

2014

2004

2012

2003

2016

Experimental Resolution

Structural biology techniques emerged that finally allow scientists to visualize protein motion at atomic resolutions.

Computational Power and Speed

Technology improved to the point that molecular dynamics simulations can be run on proteins at biologically relevant timescales useful for drug discovery.

2016

We are advancing a pipeline of promising therapeutic candidates, with an initial focus on precision oncology.